OCUL

Ocular Therapeutix Inc (OCUL)

US
$ 11.12.97%

Price Chart

Key Statistics

Market Cap
$ 1.1B
P/E Ratio
0.00
Revenue (TTM)
$ 59.65M
Volume
854.9K
52W High
$ 11.78
52W Low
$ 4.79
Dividend Yield
0.00%
Beta
1.50

Technicals

50-Day MA
7.4793
200-Day MA
8.488
52 Week High
11.775
52 Week Low
4.79

About OCUL

Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-base.

Employees
274
Headquarters
Bedford, MA
CEO
Dr. Pravin U. Dugel M.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
CLIK
Click Holdings Limi...
$ 0.69
147.61
FL
Foot Locker Inc.
$ 23.77
84.65
AYTU
Aytu BioPharma Inc....
$ 2.07
53.56
KDLY
Kindly MD Inc. Comm...
$ 11.54
49.30
GRYP
Gryphon Digital Min...
$ 1.11
48.45

Top Losers

Symbol/Name
LTP
% Chg
CGBS
Crown LNG Holdings ...
$ 0.09
-20.33
MLGO
MicroAlgo Inc. Ordi...
$ 1.77
-15.68
DKS
Dick's Sporting Goo...
$ 177.50
-15.33
UNH
UnitedHealth Group ...
$ 264.17
-14.23
LAZR
Luminar Technologie...
$ 4.04
-13.78